Cellestia Biotech AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Cellestia Biotech AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11072
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cellestia Biotech AG (Cellestia Biotech) is a biopharmaceutical company that develops anti-cancer drugs for the treatment of oncology and immunological disorders. The company’s lead compound includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. Its CB-103 blocks the notch pathway and inhibits cancerous cells in breast, lung, blood, or any other tissue of the body. Cellestia Biotech’s products finds application in the treatment of NOTCH dependent leukemia, lymphoma and solid tumors. The company conducts research and development activities in the field of oncology and cancer stem cells biology. It operates through its research laboratory located in Lausanne, Switzerland. Cellestia Biotech is headquartered in Basel, Switzerland.

Cellestia Biotech AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cellestia Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cellestia Biotech AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cellestia Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cellestia Biotech AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cellestia Biotech AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cellestia Biotech AG, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Cellestia Biotech Raises Additional USD5.2 Million in Seed Financing Round 10
Cellestia Biotech Secures Venture Funding 11
Licensing Agreements 12
Cellestia Biotech Enters into Licensing Agreement for CB-103 12
Equity Offering 13
Cellestia Biotech Spin Out from Ecole Polytechnique Federale 13
Cellestia Biotech AG – Key Competitors 14
Cellestia Biotech AG – Key Employees 15
Cellestia Biotech AG – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Corporate Communications 17
Jun 15, 2017: Cellestia Biotech extends Management Team and Scientific Advisory Board 17
Jan 31, 2017: Cellestia Biotech appoints Dr. Maximilien Murone as Chief Operating Officer 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Cellestia Biotech AG, Pharmaceuticals & Healthcare, Key Facts 2
Cellestia Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cellestia Biotech AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cellestia Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cellestia Biotech AG, Deals By Therapy Area, 2012 to YTD 2018 8
Cellestia Biotech AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cellestia Biotech Raises Additional USD5.2 Million in Seed Financing Round 10
Cellestia Biotech Secures Venture Funding 11
Cellestia Biotech Enters into Licensing Agreement for CB-103 12
Cellestia Biotech Spin Out from Ecole Polytechnique Federale 13
Cellestia Biotech AG, Key Competitors 14
Cellestia Biotech AG, Key Employees 15
Cellestia Biotech AG, Other Locations 16

List of Figures
Cellestia Biotech AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cellestia Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cellestia Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cellestia Biotech AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cellestia Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cellestia Biotech AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Cellestia Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cellestia Biotech AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Cellestia Biotech AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Orano SA:電力:M&Aディール及び事業提携情報
    Summary Orano SA (Orano), formerly New AREVA Holding, is an integrated nuclear energy company that transforms nuclear materials and provides technological solutions for power generation and allied services. It offers complete range of products and services that covers the entire nuclear fuel cycle r …
  • CivaTech Oncology Inc:医療機器:M&Aディール及び事業提携情報
    Summary CivaTech Oncology Inc (CivaTech) is a medical device company that provides radiation therapy solutions. The company develops polymer based low dose rate (LDR) brachytherapy devices for the treatment of cancer. Its product portfolio includes CivaString, a radiation therapy device to treat sol …
  • ZyGEM NZ Ltd:医療機器:M&Aディール及び事業提携情報
    Summary ZyGEM NZ Ltd (ZyGEM), a subsidiary of MicroGEM International PLC is a drug development company that develops and technologies for life science, agricultural and horticultural industries. The company produces DNA extraction products, and enzymes used in diagnostics, molecular biology and indu …
  • Celulosa Arauco y Constitucion SA:企業の戦略的SWOT分析
    Celulosa Arauco y Constitucion SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Midatech Pharma US Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Midatech Pharma US Inc (Midatech Pharma), formerly DARA BioSciences, Inc., is a pharmaceutical company which focuses on the development and commercialization of cancer treatment and supportive care products. It is a subsidiary of Midatech Pharma Plc. The company’s product portfolio includes …
  • ArcelorMittal:企業の戦略・SWOT・財務情報
    ArcelorMittal - Strategy, SWOT and Corporate Finance Report Summary ArcelorMittal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Korea Gas Corp (036460):企業の財務・戦略的SWOT分析
    Korea Gas Corp (036460) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Brooks MacDonald Group PLC (BRK):企業の財務・戦略的SWOT分析
    Brooks MacDonald Group PLC (BRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Johnson Service Group plc (JSG):企業の財務・戦略的SWOT分析
    Summary Johnson Service Group plc (JSG) is a business and consumer service provider that provides textile services. The company provides dry cleaning and textile rental services. It offers dry cleaning services such as commercial dry cleaning, specialist textile consulting, garment aftercare service …
  • Northern Ireland Electricity Networks Ltd:企業の戦略的SWOT分析
    Northern Ireland Electricity Networks Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Credit Agricole Group:企業のM&A・事業提携・投資動向
    Credit Agricole Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Credit Agricole Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Boral Limited:企業のM&A・事業提携・投資動向
    Boral Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Boral Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Pets at Home Group Plc (PETS):企業の財務・戦略的SWOT分析
    Pets at Home Group Plc (PETS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Hikma Pharmaceuticals PLC:戦略・SWOT・企業財務分析
    Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance Report Summary Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Birchcliff Energy Ltd (BIR):石油・ガス:M&Aディール及び事業提携情報
    Summary Birchcliff Energy Ltd. (Birchcliff) is an intermediate oil and gas company that explores for, develops and produces natural gas, light oil and natural gas liquids. Its product portfolio includes crude oil, natural gas, natural gas liquids, and light and medium oils. The company operates in t …
  • America’s Car-Mart, Inc. (CRMT):企業の財務・戦略的SWOT分析
    America's Car-Mart, Inc. (CRMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Tishman Realty & Construction Co., Inc.:企業の戦略・SWOT・財務情報
    Tishman Realty & Construction Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Tishman Realty & Construction Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Oxford Immunotec Ltd:企業の製品パイプライン分析
    Summary Oxford Immunotec Ltd (Oxford Immunotec) a subsidiary of Oxford Immunotec Global Plc is a medical device company that offers proprietary tests for immune-regulated conditions. The company offers in vitro diagnostic, T-SPOT CMV Test, C6 Lyme ELISA Test, T-Cell Xtend Reagent. It offers T-SPOT.T …
  • Adcock Ingram Holdings Ltd (AIP):企業の財務・戦略的SWOT分析
    Adcock Ingram Holdings Ltd (AIP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • NMDC Ltd:企業のM&A・事業提携・投資動向
    NMDC Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NMDC Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆